Paul Mattels

Stock Analyst at Stifel

(n/a)

# 4,492

Out of 4,496 analysts

3

Total ratings

n/a

Success rate

-36.38%

Average return

Main Sectors:

Top Industries:

2 Stocks

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	DNLI Denali Therapeutics	Maintains: Hold	$26 → $22	$21.46	+2.52%	2	May 8, 2024
	ALEC Alector	Initiates: Buy	n/a	$5.83	-	1	Feb 19, 2020

Denali Therapeutics

May 8, 2024

Maintains: Hold

Price Target: $26 → $22

Current: $21.46

Upside: +2.52%

Alector

Feb 19, 2020

Initiates: Buy

Price Target: n/a

Current: $5.83

Upside: -